Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
NS Therapeutic Area Biomarker Lead (Associate Director) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 11, 2024
MSL Tumeurs Solides - Nord Est Field Non-Sales (France) France International Innovative Medicines Research & Development Apr 29, 2024
MSL Manager, RLT Shanghai (Shanghai) China International Innovative Medicines Research & Development Apr 18, 2024
MSL Manager - Hematology Shanghai (Shanghai) China International Innovative Medicines Research & Development May 14, 2024
Medical Scientific Liaison Manager, Immunologie (w/m/d), Gebiet: Sachsen Saxony (with Corpus Christi) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development Oct 18, 2024
Medical Scientific Liaison İstanbul Kavacık Turkey International Innovative Medicines Research & Development Sep 26, 2024
Medical Science Liaison, Immunology Chongqing (Chongqing Province) China International Innovative Medicines Research & Development Sep 30, 2024
Medical Science Liaison Onc Prostate Radioligand Therapies Michigan Territory Field Non-Sales (USA) USA US Innovative Medicines Research & Development Oct 09, 2024
Medical Science Liaison Onc Prostate Radioligand Therapies DFW or North Remote USA US Innovative Medicines Research & Development Jun 05, 2024
Medical Science Liaison Neuro Ekaterinburg Russian Fed. International Innovative Medicines Research & Development Jul 25, 2024
Medical Science Liaison Lead Warsaw Poland International Innovative Medicines Research & Development Apr 18, 2024
Medical Science Liaison Immunology Field Force (England / Wales) United Kingdom International Innovative Medicines Research & Development Oct 10, 2024
Medical Science Liaison Hemato (Siberia) Novosibirsk Russian Fed. International Innovative Medicines Research & Development Sep 20, 2024
Medical Science Liaison Allergy / Derm MN, WI, ND, SD Remote Field Non-Sales (USA) USA US Innovative Medicines Research & Development Apr 25, 2024
Medical Science Liaison (MSL), Czech Republic Prague Czech Republic International Innovative Medicines Research & Development Sep 27, 2024
Medical Science Liaison (MSL) ONC Solid Tumor Chicago Territory Remote Field Non-Sales (USA) USA US Innovative Medicines Research & Development Oct 17, 2024
Medical Science Liaison (MSL) Neuroscience Eastern PA, Northern NJ Field Non-Sales (USA) USA US Innovative Medicines Research & Development Oct 17, 2024
Medical Science Liaison - Solid Tumors Bucuresti Romania International Innovative Medicines Research & Development Oct 17, 2024
Medical Science Liaison - Rheumatology - Ontario Field Non-Sales (Canada) Canada International Innovative Medicines Research & Development Oct 25, 2024
Medical Science Liaison - Breast Cancer Field Non-Sales (Canada) Canada International Innovative Medicines Research & Development Oct 23, 2024
Medical Science Liaison Novosibirsk Russian Fed. International Innovative Medicines Research & Development Oct 22, 2024
Medical Science Liaison West Bengal India International Innovative Medicines Research & Development Sep 02, 2024
Medical Science Liaison Guangzhou (Guangdong Province) China International Innovative Medicines Research & Development Aug 08, 2024
Medical Safety Lead (Oncology) Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 21, 2024
Medical Safety Lead Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 10, 2024
Medical Safety and Processes Manager Barcelona Gran Vía Spain Development Innovative Medicines Research & Development Oct 18, 2024
Medical Lead Copenhagen Denmark International Innovative Medicines Research & Development Oct 14, 2024
Medical Head Radioligand Therapy Rueil-Malmaison France International Innovative Medicines Research & Development Jun 02, 2024
Medical Head Oncology Milano Italy International Innovative Medicines Research & Development Oct 14, 2024
Medical Field Trainer Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Aug 29, 2024
Medical Education Manager, Breast Cancer Montreal Canada International Innovative Medicines Research & Development Oct 18, 2024
Medical Director, Renal London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Oct 23, 2024
Medical Content Lead Immunologie (m/w/d) Munich (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development Oct 25, 2024
Medical Content Lead (m/w/d), Hematology Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development Sep 09, 2024
Medical Affairs Lead Specialty Warsaw Poland International Innovative Medicines Research & Development Oct 11, 2024
Medical Affairs Lead (m/w/d), Solid Tumors Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development Sep 06, 2024
Medical Advisor, Ophtha Shanghai (Shanghai) China International Innovative Medicines Research & Development Oct 18, 2024
Medical Advisor, HEMA Shanghai (Shanghai) China International Innovative Medicines Research & Development Oct 18, 2024
Medical Advisor In Market Brands Vilvoorde Belgium International Innovative Medicines Research & Development Oct 22, 2024
Medical Advisor Shanghai (Shanghai) China International Innovative Medicines Research & Development Jul 15, 2024
Medical Advisor Kazakhstan Kazakhstan International Innovative Medicines Research & Development Oct 21, 2024
Medical Advisor Shanghai (Shanghai) China International Innovative Medicines Research & Development Sep 11, 2024
Manager, TRD Project management Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 16, 2024
Manager, Reg&Dev Policy Japan​ Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 12, 2024
Manager, Clinical Disclosure Office Barcelona Gran Vía Spain Development Innovative Medicines Research & Development Jun 20, 2024
Manager Regulatory Policy & Intelligence London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 02, 2024
Manager Regulatory Affairs Process Excellence London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 02, 2024
Maintenance Specialist Ivrea Italy International Innovative Medicines Research & Development Oct 22, 2024
Liaison en sciences médicales - Rheumatologie - Ontario Field Non-Sales (Canada) Canada International Innovative Medicines Research & Development Oct 25, 2024
Liaison en sciences médicales - Cancer du sein Field Non-Sales (Canada) Canada International Innovative Medicines Research & Development Oct 23, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia